Seres Therapeutics (MCRB) EPS (Diluted) (2020 - 2026)
Powered by 
Analysis
Seres Therapeutics (MCRB) EPS (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | Seres Therapeutics | 49.89 Mn | 49.89 Mn | - | -2.16 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.16 |
| Mar 31, 2026 | -2.15 |
| Dec 31, 2025 | -2.13 |
| Sep 30, 2025 | -2.49 |
| Jun 30, 2025 | -2.78 |
| Mar 31, 2025 | -3.05 |
| Dec 31, 2024 | -3.65 |
| Sep 30, 2024 | 14.58 |
| Jun 30, 2024 | -4.34 |
| Mar 31, 2024 | -5.56 |
| Dec 31, 2023 | -6.50 |
| Sep 30, 2023 | -7.62 |
| Jun 30, 2023 | 7.17 |
| Mar 31, 2023 | -11.36 |
| Dec 31, 2022 | -0.41 |
| Sep 30, 2022 | -9.79 |
| Jun 30, 2022 | -13.97 |
| Mar 31, 2022 | -12.21 |
| Dec 31, 2021 | -10.84 |
| Sep 30, 2021 | 14.38 |